Altered Metabolites in the Plasma of Autism Spectrum Disorder: A Capillary Electrophoresis Time-of-Flight Mass Spectroscopy Study

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Kuwabara, Hitoshi ^a   Yamasue, Hidenori ^a,b   Koike, Shinsuke ^a,c   Inoue, Hideyuki ^a   Kawakubo, Yuki ^a   Kuroda, Miho ^a,d   Takano, Yosuke ^a   Iwashiro, Norichika ^a   Natsubori, Tatsunobu ^a   Aoki, Yuta ^a   Kano, Yukiko ^a   Kasai, Kiyoto ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d SHUKUTOKU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; BIOLOGICAL MARKER; LACTIC ACID; PYROGLUTAMIC ACID; TAURINE;

ADULT; AMINO ACID ANALYSIS; AMINO ACID BLOOD LEVEL; ANALYTICAL PARAMETERS; ARTICLE; AUTISM; BLOOD ANALYSIS; BLOOD SAMPLING; CAPILLARY ELECTROPHORESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENZYME ACTIVITY; HUMAN; LACTATE BLOOD LEVEL; LIMIT OF QUANTITATION; MALE; METABOLITE; OXIDATIVE STRESS; TIME OF FLIGHT MASS SPECTROMETRY;

ADULT; ARGININE; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHILD DEVELOPMENT DISORDERS, PERVASIVE; ELECTROPHORESIS, CAPILLARY; HUMANS; LACTIC ACID; MALE; METABOLOME; OXIDATIVE STRESS; PYRROLIDONECARBOXYLIC ACID; SEVERITY OF ILLNESS INDEX; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TAURINE;

EID: 84884235800     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0073814     Document Type: Article

References (59)

1. American Psychiatric Association (2000) Diagnostic and Statistical Manual of Mental Disorders. Fourth edition. Text revision. Washington DC: American Psychiatric Association.
2. Lord C, Risi S, Lambrecht L, Cook EH Jr, Leventhal BL, et al. (2000) The autism diagnostic observation schedule-generic: a standard measure of social and communication deficits associated with the spectrum of autism. J Autism Dev Disord 30: 205-223.
3. Tsuchiya KJ, Matsumoto K, Yagi A, Inada N, Kuroda M, et al. (2013) Reliability and validity of autism diagnostic interview-revised, Japanese version. J Autism Dev Disord 43: 643-662.
4. Emond P, Mavel S, Aidoud N, Nadal-Desbarats L, Montigny F, et al. (2013) GC-MS-based urine metabolic profiling of autism spectrum disorders. Anal Bioanal Chem 405: 5291-5300.
5. Nakamura K, Anitha A, Yamada K, Tsujii M, Iwayama Y, et al. (2008) Genetic and expression analyses reveal elevated expression of syntaxin 1A (STX1A) in high functioning autism. Int J Neuropsychopharmacol 11: 1073-1084.
6. Quinones MP, Kaddurah-Daouk R, (2009) Metabolomics tools for identifying biomarkers for neuropsychiatric diseases. Neurobiol Dis 35: 165-176.
7. Suzuki K, Nishimura K, Sugihara G, Nakamura K, Tsuchiya KJ, et al. (2010) Metabolite alterations in the hippocampus of high-functioning adult subjects with autism. Int J Neuropsychopharmacol 13: 529-534.
8. Kaiser MD, Hudac CM, Shultz S, Lee SM, Cheung C, et al. (2010) Neural signatures of autism. Proc Natl Acad Sci U S A 107: 21223-21228.
9. Iwata K, Matsuzaki H, Miyachi T, Shimmura C, Suda S, et al. (2011) Investigation of the serum levels of anterior pituitary hormones in male children with autism. Mol Autism 2: 16.
10. Zheng P, Gao HC, Li Q, Shao WH, Zhang ML, et al. (2012) Plasma metabonomics as a novel diagnostic approach for major depressive disorder. J Proteome Res 11: 1741-1748.
11. Xu XH, Huang Y, Wang G, Chen SD, (2012) Metabolomics: a novel approach to identify potential diagnostic biomarkers and pathogenesis in Alzheimer's disease. Neurosci Bull 28: 641-648.
12. Pilling S, Baron-Cohen S, Megnin-Viggars O, Lee R, Taylor C, (2012) Recognition, referral, diagnosis, and management of adults with autism: summary of NICE guidance. BMJ 344: e4082.
13. Yap IK, Angley M, Veselkov KA, Holmes E, Lindon JC, et al. (2010) Urinary metabolic phenotyping differentiates children with autism from their unaffected siblings and age-matched controls. J Proteome Res 9: 2996-3004.
14. Ming X, Stein TP, Barnes V, Rhodes N, Guo L, (2012) Metabolic perturbance in autism spectrum disorders: a metabolomics study. J Proteome Res 11: 5856-5862.
15. Cai HL, Li HD, Yan XZ, Sun B, Zhang Q, et al. (2012) Metabolomic analysis of biochemical changes in the plasma and urine of first-episode neuroleptic-naive schizophrenia patients after treatment with risperidone. J Proteome Res 11: 4338-4350.
16. Schicho R, Shaykhutdinov R, Ngo J, Nazyrova A, Schneider C, et al. (2012) Quantitative Metabolomic Profiling of Serum, Plasma, and Urine by (1)H NMR Spectroscopy Discriminates between Patients with Inflammatory Bowel Disease and Healthy Individuals. J Proteome Res.
17. Soga T, Baran R, Suematsu M, Ueno Y, Ikeda S, et al. (2006) Differential metabolomics reveals ophthalmic acid as an oxidative stress biomarker indicating hepatic glutathione consumption. J Biol Chem 281: 16768-16776.
18. Sugimoto M, Hirayama A, Robert M, Abe S, Soga T, et al. (2010) Prediction of metabolite identity from accurate mass, migration time prediction and isotopic pattern information in CE-TOFMS data. Electrophoresis 31: 2311-2318.
19. Hirayama A, Kami K, Sugimoto M, Sugawara M, Toki N, et al. (2009) Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry. Cancer Res 69: 4918-4925.
20. Soga T, Sugimoto M, Honma M, Mori M, Igarashi K, et al. (2011) Serum metabolomics reveals gamma-glutamyl dipeptides as biomarkers for discrimination among different forms of liver disease. J Hepatol 55: 896-905.
21. Yamasue H, Kuwabara H, Kawakubo Y, Kasai K, (2009) Oxytocin, sexually dimorphic features of the social brain, and autism. Psychiatry Clin Neurosci 63: 129-140.
22. Baron-Cohen S, Lombardo MV, Auyeung B, Ashwin E, Chakrabarti B, et al. (2011) Why are autism spectrum conditions more prevalent in males? PLoS Biol 9: e1001081.
23. Aoki Y, Abe O, Yahata N, Kuwabara H, Natsubori T, et al. (2012) Absence of age-related prefrontal NAA change in adults with autism spectrum disorders. Transl Psychiatry 2: e178.
24. Watanabe T, Yahata N, Abe O, Kuwabara H, Inoue H, et al. (2012) Diminished medial prefrontal activity behind autistic social judgments of incongruent information. PLoS One 7: e39561.
25. Lecavalier L, Aman MG, Scahill L, McDougle CJ, McCracken JT, et al. (2006) Validity of the autism diagnostic interview-revised. Am J Ment Retard 111: 199-215.
26. Matsuoka K, Uno M, Kasai K, Koyama K, Kim Y, (2006) Estimation of premorbid IQ in individuals with Alzheimer's disease using Japanese ideographic script (Kanji) compound words: Japanese version of National Adult Reading Test. Psychiatry Clin Neurosci 60: 332-339.
27. Matsuoka K, Kim Y (2006) Japanese Adult Reading Test. Tokyo: Shinko-Igaku Publishers.
28. Wechsler D (1981) Wechsler Adult Intelligence Scale-Revised. New York: Psychological Corporation.
29. Wechsler D (1997) Wechsler Adult Intelligence Scale, 3rd edition. San Antonio: The Psychological Corporation.
30. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, et al. (1998) The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59 Suppl 20: 22-33;quiz 34-57.
31. Ooga T, Sato H, Nagashima A, Sasaki K, Tomita M, et al. (2011) Metabolomic anatomy of an animal model revealing homeostatic imbalances in dyslipidaemia. Mol Biosyst 7: 1217-1223.
32. Baran R, Kochi H, Saito N, Suematsu M, Soga T, et al. (2006) MathDAMP: a package for differential analysis of metabolite profiles. BMC Bioinformatics 7: 530.
33. Ohashi Y, Hirayama A, Ishikawa T, Nakamura S, Shimizu K, et al. (2008) Depiction of metabolome changes in histidine-starved Escherichia coli by CE-TOFMS. Mol Biosyst 4: 135-147.
34. Johannesen JK, O'Donnell BF, Shekhar A, McGrew JH, Hetrick WP (2012) Diagnostic Specificity of Neurophysiological Endophenotypes in Schizophrenia and Bipolar Disorder. Schizophr Bull.
35. Delwing D, Bavaresco CS, Wyse AT, (2008) Protective effect of nitric oxide synthase inhibition or antioxidants on brain oxidative damage caused by intracerebroventricular arginine administration. Brain Res 1193: 120-127.
36. Zoroglu SS, Yurekli M, Meram I, Sogut S, Tutkun H, et al. (2003) Pathophysiological role of nitric oxide and adrenomedullin in autism. Cell Biochem Funct 21: 55-60.
37. Shimmura C, Suda S, Tsuchiya KJ, Hashimoto K, Ohno K, et al. (2011) Alteration of plasma glutamate and glutamine levels in children with high-functioning autism. PLoS One 6: e25340.
38. Macciardi F, Lucca A, Catalano M, Marino C, Zanardi R, et al. (1990) Amino acid patterns in schizophrenia: some new findings. Psychiatry Res 32: 63-70.
39. Talkowski ME, Rosenfeld JA, Blumenthal I, Pillalamarri V, Chiang C, et al. (2012) Sequencing chromosomal abnormalities reveals neurodevelopmental loci that confer risk across diagnostic boundaries. Cell 149: 525-537.
40. Kim HW, Cho SC, Kim JW, Cho IH, Kim SA, et al. (2009) Family-based association study between NOS-I and-IIA polymorphisms and autism spectrum disorders in Korean trios. Am J Med Genet B Neuropsychiatr Genet 150B: 300-306.
41. O'Donovan MC, Craddock N, Norton N, Williams H, Peirce T, et al. (2008) Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat Genet 40: 1053-1055.
42. Saransaari P, Oja SS, (2000) Taurine and neural cell damage. Amino Acids 19: 509-526.
43. Moreno-Fuenmayor H, Borjas L, Arrieta A, Valera V, Socorro-Candanoza L, (1996) Plasma excitatory amino acids in autism. Invest Clin 37: 113-128.
44. Geier DA, Kern JK, Garver CR, Adams JB, Audhya T, et al. (2009) A prospective study of transsulfuration biomarkers in autistic disorders. Neurochem Res 34: 386-393.
45. Kern JK, Geier DA, Adams JB, Garver CR, Audhya T, et al. (2011) A clinical trial of glutathione supplementation in autism spectrum disorders. Med Sci Monit 17: CR677-682.
46. Tu WJ, Chen H, He J, (2012) Application of LC-MS/MS analysis of plasma amino acids profiles in children with autism. J Clin Biochem Nutr 51: 248-249.
47. Good P, (2011) Does fever relieve autistic behavior by improving brain blood flow? Neuropsychol Rev 21: 66-67.
48. Good P, (2011) Do salt cravings in children with autistic disorders reveal low blood sodium depleting brain taurine and glutamine? Med Hypotheses 77: 1015-1021.
49. Meister A, (1991) Glutathione deficiency produced by inhibition of its synthesis, and its reversal; applications in research and therapy. Pharmacol Ther 51: 155-194.
50. Pederzolli CD, Sgaravatti AM, Braum CA, Prestes CC, Zorzi GK, et al. (2007) 5-Oxoproline reduces non-enzymatic antioxidant defenses in vitro in rat brain. Metab Brain Dis 22: 51-65.
51. Pederzolli CD, Mescka CP, Zandona BR, de Moura Coelho D, Sgaravatti AM, et al. (2010) Acute administration of 5-oxoproline induces oxidative damage to lipids and proteins and impairs antioxidant defenses in cerebral cortex and cerebellum of young rats. Metab Brain Dis 25: 145-154.
52. Rossignol DA, Frye RE, (2012) Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis. Mol Psychiatry 17: 290-314.
53. Fillano JJ, Goldenthal MJ, Rhodes CH, Marin-Garcia J, (2002) Mitochondrial dysfunction in patients with hypotonia, epilepsy, autism, and developmental delay: HEADD syndrome. J Child Neurol 17: 435-439.
54. Filipek PA, Juranek J, Smith M, Mays LZ, Ramos ER, et al. (2003) Mitochondrial dysfunction in autistic patients with 15q inverted duplication. Ann Neurol 53: 801-804.
55. Correia C, Coutinho AM, Diogo L, Grazina M, Marques C, et al. (2006) Brief report: High frequency of biochemical markers for mitochondrial dysfunction in autism: no association with the mitochondrial aspartate/glutamate carrier SLC25A12 gene. J Autism Dev Disord 36: 1137-1140.
56. Giulivi C, Zhang YF, Omanska-Klusek A, Ross-Inta C, Wong S, et al. (2010) Mitochondrial dysfunction in autism. JAMA 304: 2389-2396.
57. Oliveira G, Diogo L, Grazina M, Garcia P, Ataide A, et al. (2005) Mitochondrial dysfunction in autism spectrum disorders: a population-based study. Dev Med Child Neurol 47: 185-189.
58. Weiss LA, Shen Y, Korn JM, Arking DE, Miller DT, et al. (2008) Association between microdeletion and microduplication at 16p11.2 and autism. N Engl J Med 358: 667-675.
59. McCarthy SE, Makarov V, Kirov G, Addington AM, McClellan J, et al. (2009) Microduplications of 16p11.2 are associated with schizophrenia. Nat Genet 41: 1223-1227.